Automation Opportunities in Pharmacovigilance: An Industry Survey-Reference-Cited by-同舟云学术

Automation Opportunities in Pharmacovigilance: An Industry Survey

Published:2020-02 Issue:1 Volume:34 Page:7-18
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

Ghosh Rajesh^ORCID,Kempf Dieter,Pufko Angela,Barrios Martinez Luisa Fernanda,Davis Chris M.,Sethi Sundeep

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40290-019-00320-0.pdf

Reference18 articles.

1. TransCelerate. Intelligent Automation Opportunities in Pharmacovigilance. https://transceleratebiopharmainc.com/initiatives/intelligent-automation-opportunities-pharmacovigilance/. Accessed 30 Nov 2019.

2. Stergiopoulos S, Fehrle M, Caubel P, et al. Adverse drug reaction case safety practices in large biopharmaceutical organizations from 2007 to 2017: an industry survey. Pharm Med. 2019;33(6):499–510.

3. US Food and Drug Administration. Reports Received and Reports Entered into FAERS by Year. https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/reports-received-and-reports-entered-faers-year. Published 10 Nov 2015. Accessed 26 Nov 2019.

4. Yang M, Kiang M, Shang W. Filtering big data from social media—Building an early warning system for adverse drug reactions. J Biomed Inform. 2015;54:230–40.

5. Freifeld CC, Brownstein JS, Menone CM, et al. Digital drug safety surveillance: monitoring pharmaceutical products in Twitter. Drug Saf. 2014;37(5):343–50.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Dawn of a New Pharmaceutical Epoch: Can AI and Robotics Reshape Drug Formulation?;Advanced Healthcare Materials;2024-08-18

2. Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance Centers;Drug Safety;2024-05-08

3. Enhancing the Efficiency of the Individual Case Safety Report (ICSR) Quality and Compliance through Automation;Current Drug Safety;2024-05

4. Data-Driven Identification of Factors That Influence the Quality of Adverse Event Reports: 15-Year Interpretable Machine Learning and Time-Series Analyses of VigiBase and QUEST;JMIR Medical Informatics;2024-04-03

5. Navigating duplication in pharmacovigilance databases: a scoping review;BMJ Open;2024-04